Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
TauRx Announces Results from Phase 3 Alzheimer's Disease Study, LUCIDITY, Assuring Path for Regulatory Submissions
2022-10-06 18:00
Cytiva strengthens cell line development with CEVEC acquisition
2022-10-06 14:00
Servier unveils its 2030 ambition and reveals a new visual identity
2022-10-06 13:30
ASTRAZENECA, First Organization in Egypt receiving Best place to work for Millennials Award
2022-10-05 22:59
Ascletis Announces Dosing of the First Patient in Phase II Clinical Trial of THRβ Agonist ASC41 for 52-Week Treatment of Liver Biopsy-Proven NASH
2022-10-05 08:10
Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting Antibody TST004 for the Treatment of IgA Nephropathy
2022-10-05 08:00
HAVAS HEALTH & YOU APPOINTS PAUL PFLEIDERER AS PRESIDENT OF HAVAS LIFE NEW YORK
2022-10-04 21:00
HanAll's Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner
2022-10-04 19:00
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry
2022-10-04 14:00
DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY
2022-10-03 15:00
AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease
2022-10-03 09:00
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022
2022-10-01 04:30
Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2023
2022-10-01 00:53
YS BIOPHARMA TO MERGE WITH NASDAQ-LISTED SUMMIT HEALTHCARE ACQUISITION CORP.
2022-09-30 04:01
First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent
2022-09-30 02:30
Doxy.me extends telemedicine's reach to 88% of the world's population
2022-09-29 22:03
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
2022-09-29 19:00
NeuShen Therapeutics Closes Pre-A Financing with ~$20M
2022-09-29 17:50
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC
2022-09-29 14:22
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc
2022-09-29 11:32
1
111
112
113
114
115
377